|
Product Name: | ML-109 | Synonyms: | ML-109;Acetamide, N-[4-[[2-methoxy-5-[1,2,3,4-tetrahydro-5-hydroxy-4-oxo-3-(phenylmethyl)-2-quinazolinyl]phenyl]methoxy]phenyl]-;N-[4-[[2-Methoxy-5-[1,2,3,4-tetrahydro-5-hydroxy-4-oxo-3-(phenylmethyl)-2-quinazolinyl]phenyl]methoxy]phenyl]acetamide;ML-109 (CID-25246343);TSH Receptor,Thyrotropin receptor,inhibit,ML-109,ML 109,Inhibitor,Thyroid-stimulating hormone Receptor,ML109;N-(4-((5-(3-Benzyl-5-hydroxy-4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl)-2-methoxybenzyl)oxy)phenyl)acetamide;N-(4-{[5-(3-benzyl-5-hydroxy-4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl)-2-methoxyphenyl]methoxy}phenyl)acetamide | CAS: | 1186649-91-1 | MF: | C31H29N3O5 | MW: | 523.58 | EINECS: | | Product Categories: | API | Mol File: | 1186649-91-1.mol | |
| ML-109 Chemical Properties |
Boiling point | 810.1±65.0 °C(Predicted) | density | 1.300±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO:83.0(Max Conc. mg/mL);158.5(Max Conc. mM) | form | Solid | pka | 8.66±0.40(Predicted) | color | White to light yellow |
| ML-109 Usage And Synthesis |
Definition | ChEBI: N-[4-[[5-[5-hydroxy-4-oxo-3-(phenylmethyl)-1,2-dihydroquinazolin-2-yl]-2-methoxyphenyl]methoxy]phenyl]acetamide is a member of quinazolines. |
| ML-109 Preparation Products And Raw materials |
|